These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11589443)

  • 1. Primary prevention of cardiovascular events.
    Jackson R
    N Z Med J; 2001 Aug; 114(1138):387. PubMed ID: 11589443
    [No Abstract]   [Full Text] [Related]  

  • 2. An educational and behavioral approach for the primary prevention of premature cardiovascular disease.
    Allred CA; Smith RP; Dudenas VC; Ayers CR
    J Am Diet Assoc; 1984 Sep; 84(9):1042-3. PubMed ID: 6470376
    [No Abstract]   [Full Text] [Related]  

  • 3. Meta-analysis of data from the six primary prevention trials of cardiovascular events using aspirin.
    Bartolucci AA; Howard G
    Am J Cardiol; 2006 Sep; 98(6):746-50. PubMed ID: 16950176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of aspirin treatment in the primary prevention of cardiovascular disease events in subgroups based on age, gender, and varying cardiovascular risk.
    Greving JP; Buskens E; Koffijberg H; Algra A
    Circulation; 2008 Jun; 117(22):2875-83. PubMed ID: 18506010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Secondary prevention of cardiovascular diseases is a priority, yet the results, so far, are insufficient].
    Rodríguez Artalejo F; del Rey Calero J
    Rev Esp Salud Publica; 1999; 73(4):441-3. PubMed ID: 10575932
    [No Abstract]   [Full Text] [Related]  

  • 6. [Primary and secondary prevention of cardiovascular diseases--metabolic aspects].
    Schlierf G
    Internist (Berl); 1981 Feb; 22(2):68-71. PubMed ID: 7012071
    [No Abstract]   [Full Text] [Related]  

  • 7. Statins reduce cardiovascular events in primary and secondary prevention trials without causing an increase in carcinoma.
    Aronow WS
    J Am Geriatr Soc; 2009 Oct; 57(10):1942-3; author reply 1943-4. PubMed ID: 19807799
    [No Abstract]   [Full Text] [Related]  

  • 8. Usefulness of pravastatin in primary prevention of cardiovascular events in women: analysis of the Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA study).
    Mizuno K; Nakaya N; Ohashi Y; Tajima N; Kushiro T; Teramoto T; Uchiyama S; Nakamura H;
    Circulation; 2008 Jan; 117(4):494-502. PubMed ID: 18172039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of U.S. guidelines in other countries: aspirin for the primary prevention of cardiovascular events in Japan.
    Morimoto T; Fukui T; Lee TH; Matsui K
    Am J Med; 2004 Oct; 117(7):459-68. PubMed ID: 15464702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acetylsalicylic acid in patients with diabetes mellitus: can be used for secondary but not primary prevention of cardiovascular events].
    Klomp CM; ten Cate H; Stehouwer CD; Schaper NC
    Ned Tijdschr Geneeskd; 2009; 153():A109. PubMed ID: 19785798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins for the primary prevention of cardiovascular events in elderly patients: a picture from clinical practice without strong evidence from clinical trials.
    Trifirò G; Alacqua M; Corrao S; Tari M; Arcoraci V
    J Am Geriatr Soc; 2008 Jan; 56(1):175-7. PubMed ID: 18184214
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparison of population versus individual based cardiovascular disease prevention programs in Västerbotten, Sweden.
    Rudholm N
    Health Policy; 2006 Aug; 78(1):70-6. PubMed ID: 16280184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Primary prevention of cardiovascular disease].
    Gohlke H
    Dtsch Med Wochenschr; 2005 Jan; 130(1-2):38-43. PubMed ID: 15619173
    [No Abstract]   [Full Text] [Related]  

  • 14. Integrated community control of chronic diseases--experiences in the GDR.
    Heinemann L; Heine H
    Przegl Lek; 1985; 42(8):614-20. PubMed ID: 4089217
    [No Abstract]   [Full Text] [Related]  

  • 15. [The primary prevention of the cardiovascular disease begins in the infancy].
    Vázquez-Antona CA
    Arch Cardiol Mex; 2007; 77(1):7-10. PubMed ID: 17500186
    [No Abstract]   [Full Text] [Related]  

  • 16. [Primary prevention and screening in adults: update 2006].
    Cornuz J; Guessous I; Rodondi N
    Rev Med Suisse; 2006 Jan; 2(50):262-73. PubMed ID: 16503042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin for the primary prevention of cardiovascular events: recommendations and rationale.
    U.S. Preventive Services Task Force
    Am Fam Physician; 2002 May; 65(10):2107-10. PubMed ID: 12046780
    [No Abstract]   [Full Text] [Related]  

  • 18. [The polypill: optimal strategy for reduction of cardiovascular disease].
    Nathoe HM; Doevendans PA
    Ned Tijdschr Geneeskd; 2005 Jul; 149(31):1740. PubMed ID: 16114290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin for the primary prevention of cardiovascular events: recommendations and rationale.
    U.S. Preventive Services Task Force
    Am J Nurs; 2002 Mar; 102(3):67, 69-70. PubMed ID: 11976531
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cardiovascular prevention in the over-80 age group is not beneficial].
    de Ruijter W; Gussekloo J
    Ned Tijdschr Geneeskd; 2008 Jan; 152(1):27. PubMed ID: 18240758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.